Copyright Reports & Markets. All rights reserved.

Global DTaP and Tdap Vaccines Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on DTaP and Tdap Vaccines Industry
  • 1.7 COVID-19 Impact: DTaP and Tdap Vaccines Market Trends

    • 2 Global DTaP and Tdap Vaccines Quarterly Market Size Analysis

    • 2.1 DTaP and Tdap Vaccines Business Impact Assessment - COVID-19
      • 2.1.1 Global DTaP and Tdap Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global DTaP and Tdap Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global DTaP and Tdap Vaccines Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global DTaP and Tdap Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global DTaP and Tdap Vaccines Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers DTaP and Tdap Vaccines Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into DTaP and Tdap Vaccines Market
    • 3.5 Key Manufacturers DTaP and Tdap Vaccines Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on DTaP and Tdap Vaccines Segments, By Type

    • 4.1 Introduction
      • 1.4.1 DTaP
      • 1.4.2 Td
      • 1.4.3 Tdap
    • 4.2 By Type, Global DTaP and Tdap Vaccines Market Size, 2019-2021
      • 4.2.1 By Type, Global DTaP and Tdap Vaccines Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global DTaP and Tdap Vaccines Price, 2020-2021

    5 Impact of Covid-19 on DTaP and Tdap Vaccines Segments, By Application

    • 5.1 Overview
      • 5.5.1 Adult
      • 5.5.2 Pediatric
    • 5.2 By Application, Global DTaP and Tdap Vaccines Market Size, 2019-2021
      • 5.2.1 By Application, Global DTaP and Tdap Vaccines Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global DTaP and Tdap Vaccines Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Sanofi Pasteur
      • 7.1.1 Sanofi Pasteur Business Overview
      • 7.1.2 Sanofi Pasteur DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Product Introduction
      • 7.1.4 Sanofi Pasteur Response to COVID-19 and Related Developments
    • 7.2 GlaxoSmithKline
      • 7.2.1 GlaxoSmithKline Business Overview
      • 7.2.2 GlaxoSmithKline DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Product Introduction
      • 7.2.4 GlaxoSmithKline Response to COVID-19 and Related Developments
    • 7.3 Protein Sciences Corporation
      • 7.3.1 Protein Sciences Corporation Business Overview
      • 7.3.2 Protein Sciences Corporation DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Product Introduction
      • 7.3.4 Protein Sciences Corporation Response to COVID-19 and Related Developments
    • 7.4 Novartis AG
      • 7.4.1 Novartis AG Business Overview
      • 7.4.2 Novartis AG DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.4.3 Novartis AG DTaP and Tdap Vaccines Product Introduction
      • 7.4.4 Novartis AG Response to COVID-19 and Related Developments
    • 7.5 Seqirus
      • 7.5.1 Seqirus Business Overview
      • 7.5.2 Seqirus DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.5.3 Seqirus DTaP and Tdap Vaccines Product Introduction
      • 7.5.4 Seqirus Response to COVID-19 and Related Developments
    • 7.6 Merck Sharp & Dohme Corp
      • 7.6.1 Merck Sharp & Dohme Corp Business Overview
      • 7.6.2 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Introduction
      • 7.6.4 Merck Sharp & Dohme Corp Response to COVID-19 and Related Developments
    • 7.7 Astellas Pharma US, Inc
      • 7.7.1 Astellas Pharma US, Inc Business Overview
      • 7.7.2 Astellas Pharma US, Inc DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Introduction
      • 7.7.4 Astellas Pharma US, Inc Response to COVID-19 and Related Developments
    • 7.8 Pfizer Inc
      • 7.8.1 Pfizer Inc Business Overview
      • 7.8.2 Pfizer Inc DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.8.3 Pfizer Inc DTaP and Tdap Vaccines Product Introduction
      • 7.8.4 Pfizer Inc Response to COVID-19 and Related Developments
    • 7.9 Johnson & Johnson
      • 7.9.1 Johnson & Johnson Business Overview
      • 7.9.2 Johnson & Johnson DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.9.3 Johnson & Johnson DTaP and Tdap Vaccines Product Introduction
      • 7.9.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.10 Lanzhou Institute of Biological Products Co., Ltd
      • 7.10.1 Lanzhou Institute of Biological Products Co., Ltd Business Overview
      • 7.10.2 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Introduction
      • 7.10.4 Lanzhou Institute of Biological Products Co., Ltd Response to COVID-19 and Related Developments
    • 7.11 AstraZeneca
      • 7.11.1 AstraZeneca Business Overview
      • 7.11.2 AstraZeneca DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.11.3 AstraZeneca DTaP and Tdap Vaccines Product Introduction
      • 7.11.4 AstraZeneca Response to COVID-19 and Related Developments
    • 7.12 Emergent BioSolutions Inc
      • 7.12.1 Emergent BioSolutions Inc Business Overview
      • 7.12.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Quarterly Production and Revenue, 2020
      • 7.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Introduction
      • 7.12.4 Emergent BioSolutions Inc Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 DTaP and Tdap Vaccines Supply Chain Analysis
      • 8.1.1 DTaP and Tdap Vaccines Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on DTaP and Tdap Vaccines Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 DTaP and Tdap Vaccines Distribution Channels
      • 8.2.2 Covid-19 Impact on DTaP and Tdap Vaccines Distribution Channels
      • 8.2.3 DTaP and Tdap Vaccines Distributors
    • 8.3 DTaP and Tdap Vaccines Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of DTaP and Tdap Vaccines, including the following market information:
      Global DTaP and Tdap Vaccines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global DTaP and Tdap Vaccines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global DTaP and Tdap Vaccines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global DTaP and Tdap Vaccines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Sanofi Pasteur, GlaxoSmithKline, Protein Sciences Corporation, Novartis AG, Seqirus, Merck Sharp & Dohme Corp, Astellas Pharma US, Inc, Pfizer Inc, Johnson & Johnson, Lanzhou Institute of Biological Products Co., Ltd, AstraZeneca, Emergent BioSolutions Inc, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      DTaP
      Td
      Tdap

      Based on the Application:
      Adult
      Pediatric

      Buy now